$53.63
+2.34 (+4.56%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+26.22%
1Y
+99.52%
YTD
+26.52%
Open$51.96
Previous Close$51.29
Day High$53.81
Day Low$51.92
52W High$53.81
52W Low$22.61
Volume—
Avg Volume1.53M
Market Cap4.28B
P/E Ratio48.62
EPS$1.08
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$40.85
Above
SMA 200
$34.09
Above
RSI (14)
37.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
-12.6% upside
Current
$53.63
$53.63
Target
$46.85
$46.85
$30.44
$46.85 avg
$57.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 512.13M | 425.47M | 507.99M |
| Net Income | 65.71M | 49.13M | -2,027,984 |
| Profit Margin | 12.8% | 12.2% | -0.4% |
| EBITDA | 65.05M | 51.34M | -2,983,128 |
| Free Cash Flow | — | — | -1,866,923 |
| Rev Growth | +20.4% | +20.4% | +16.6% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |